Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Italian heart pump registry launches to track Long-Term survival

NCT ID NCT07458074

Knowledge-focused Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is observing 400 adults with advanced heart failure who have received a continuous-flow ventricular assist device (VAD), a mechanical pump that helps the heart circulate blood. Researchers will track survival rates in the hospital and at one and five years after implantation, as well as complications like bleeding, infection, and organ failure. The goal is to gather real-world data to improve care, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2025

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with advanced heart failure refractory to maximal medical therapy, and therefore undergoing continuous-flow (centrifugal/radial) VAD implantation, will be recruited

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients with advanced heart failure refractory to maximal medical therapy, and therefore undergoing implantation of continuous-flow (radial) VAD devices, will be recruited * Only the adult population will be included * Continuous-flow implantable BIVAD systems are also included. Exclusion Criteria: * Mechanical devices other than those specified * Paracorporeal pulsatile devices and total artificial heart (TAH).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced heart failure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

advanced heart failure heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    13 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Azienda Ospedale Università Padova

    NOT_YET_RECRUITING

    Padova, Padova, Italy

  • Azienda Ospedaliera San Camillo Forlanini di Roma

    NOT_YET_RECRUITING

    Roma, Roma, Italy

  • Azienda Ospedaliera Universitaria Integrata Verona

    NOT_YET_RECRUITING

    Verona, Verona, Italy

  • Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino

    NOT_YET_RECRUITING

    Torino, Torino, Italy

  • Azienda Ospedaliero-Universitaria Senese

    NOT_YET_RECRUITING

    Siena, Siena, Italy

  • Azienda Sanitaria Universitaria integrata di Udine

    NOT_YET_RECRUITING

    Udine, Udine, Italy

  • I.R.C.C.S. Ospedale San Raffaele Milano

    NOT_YET_RECRUITING

    Milan, Milano, Italy

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    RECRUITING

    Bologna, Bologna, 40138, Italy

  • ISMETT, Istituto di Ricovero e Cura a Carattere Scientifico

    NOT_YET_RECRUITING

    Palermo, Palermo, Italy

  • Ospedale Niguarda, Milano

    NOT_YET_RECRUITING

    Milan, Milano, Italy

  • Ospedale Policlinico San Martino

    NOT_YET_RECRUITING

    Genova, Genova, Italy

  • Ospedale di Bergamo, ASST Papa Giovanni XXIII, Bergamo

    NOT_YET_RECRUITING

    Bergamo, Bergamo, Italy

  • Policlinico San Matteo Pavia Fondazione IRCCS

    NOT_YET_RECRUITING

    Pavia, Pavia, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.